Pica in mice as a new model for the study of emesis

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 24, Issue 3, 2002, Pages 135-138

  Yamamoto, K ^a   Matsunaga, S ^a   Matsui, M ^a   Takeda, N ^a   Yamatodani, Atsushi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Carmine; Cisplatin; Emesis; Feces; Mice; Ondansetron; Pica; Spectrophotometry

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; APOMORPHINE; CARMINIC ACID; CISPLATIN; COPPER SULFATE; KAOLIN; ONDANSETRON; SEROTONIN 3 ANTAGONIST; SODIUM CHLORIDE;

ANALYTIC METHOD; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; FECES ANALYSIS; INGESTION; MALE; METHODOLOGY; MOUSE; NONHUMAN; PICA; QUANTITATIVE ANALYSIS; ROTATION; VOMITING; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; EATING; FECES; INSTITUTE FOR CANCER RESEARCH MOUSE; PSYCHOLOGICAL ASPECT;

ANIMAL; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CARMINE; CISPLATIN; DISEASE MODELS, ANIMAL; EATING; FECES; KAOLIN; MALE; MICE; MICE, INBRED ICR; ONDANSETRON; PICA; VOMITING; ANIMALS;

EID: 0035989671     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2002.24.3.802297     Document Type: Article

References (16)

1. Poison induced pica in rats
2. Pica in rats is analogous to emesis: An animal model in emesis research
3. Neuropharmacological mechanisms of emesis. I. Effects of antiemetic drugs on motion- and apomorphine-induced pica in rats
4. Neuropharmacological mechanisms of emesis. II. Effects of antiemetic drugs on cisplatin-induced pica in rats
5. Histaminergic mechanism of motion sickness: Neurochemical and neuropharmacological studies in rats
6. Pica as an index motion sickness in rats
7. A mouse model for emesis research
8. Carmine as an index of transit time in children with simple constipation
9. Motion sickness-induced pica in the rat
10. Two methods to assess the gastrointestinal transit-time in mice
11. A simple method to determine the transit time in mice
12. Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism
13. 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis
14. Physiology of chemotherapy-induced emesis and antiemetic therapy: Predictive models for evaluation of new compounds
15. Progress in reducing nausea and emesis. Comparison of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban)
16. 3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy